4.5 Article

Growth differentiating factor-15 and adiposity in young adults: The African-PREDICT study

Journal

INTERNATIONAL JOURNAL OF OBESITY
Volume 45, Issue 7, Pages 1418-1427

Publisher

SPRINGERNATURE
DOI: 10.1038/s41366-021-00803-8

Keywords

-

Funding

  1. South African Medical Research Council (SAMRC)
  2. National Treasury
  3. South African Research Chairs Initiative (SARChI) of the Department of Science and Technology and National Research Foundation (NRF) of South Africa [GUN 86895]
  4. South African National Department of Health
  5. UK Medical Research Council
  6. UK Government's Newton Fund
  7. Pfizer (South Africa)
  8. Boehringer-Ingelheim (South Africa)
  9. Novartis (South Africa)
  10. Medi Clinic Hospital Group (South Africa)
  11. SAMRC
  12. GlaxoSmithKline R&D (Africa Non-Communicable Disease Open Lab grant)
  13. Roche Diagnostics (South Africa)

Ask authors/readers for more resources

The study aimed to investigate the relationship between GDF-15 levels and various indicators such as body weight, waist circumference, BMI, and leptin in young adults. The results showed that in the overweight/obese group, these indicators were positively associated with GDF-15, while in the underweight group they were negatively associated with GDF-15.
Background and aims Circulating growth differentiation factor-15 (GDF-15) is a stress-responsive cytokine that increases in older individuals with established cardiovascular disease (CVD) and obesity. To address potential targets in primary prevention, we aimed to determine whether body weight, waist circumference, waist/height ratio, body mass index (BMI), body surface area (BSA) and leptin associate with GDF-15 in young underweight, lean and overweight/obese (ow/ob) adults. Methods and results We included 1189 adults aged 20-30 years. We grouped participants as underweight (BMI <= 18 kg/m(2), n = 59), lean (BMI > 18 kg/m(2) and <= 25 kg/m(2); n = 616) or ow/ob (BMI >= 25 kg/m(2); n = 514) and determined serum GDF-15 and leptin levels. Body composition measurements, leptin and blood pressure readings were higher in the ow/ob group compared to the underweight and lean groups (all p < 0.0001). GDF-15 was higher in the underweight group compared to the lean and combined ow/ob groups (p = 0.041), and higher in obese (BMI >= 30 kg/m(2)) compared to overweight (p = 0.002) individuals. In multiple regression analysis, we found positive associations (all p <= 0.020) of body weight (adj. R-2 = 0.398; beta = 0.11), waist circumference (adj. R-2 = 0.271; beta = 0.11), waist/height ratio (adj. R-2 = 0.168; beta = 0.14), BMI (adj. R-2 = 0.263; beta = 0.14), BSA (adj. R-2 = 0.508; beta = 0.083) and leptin (adj. R-2 = 0.622; beta = 0.10) with GDF-15 in the ow/ob group. However, waist circumference (adj. R-2 = 0.536; beta = -0.45), waist/height ratio (adj. R-2 = 0.471; beta = -0.51) and leptin (adj. R-2 = 434; beta = -0.25) associated inversely with GDF-15 in the underweight group (all p < 0.050). Conclusion Our findings may suggest that in young adults with either underweight or excess adiposity, increased GDF-15 levels may contribute to the development of future cardiovascular health risks associated with pro-inflammation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available